Robatumumab (Anti-IGF1R / CD221)Robatumumab (Anti-IGF1R / CD221)
Move your mouse over image or click to enlarge

Robatumumab (Anti-IGF1R / CD221)

Robatumumab (Anti-IGF1R / CD221) is an antibody targeting human IGF-1R (insulin-like growth factor receptor-1). It shows anti-tumor activity and anti-proliferative activity to cancer cells and can be used in osteosarcoma and Ewing sarcoma research. MW :144.6 KD
Cat# Size Price Qty Buy
A3044-1mg*25 1mg*25
£2,432.00
A3044-1mg*5 1mg*5
£794.00
A3044-1mg 1mg
£303.00

Additional Information

Property Value or Rating
Manufacturer Selleck Chemicals LLC
Manufacturer Cat# A3044

Related Documents